Atlas Trials

Uveitis, Intermediate

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Uveitis, Intermediate

RecordFirmDate
Ozurdex Monotherapy Trial (NCT05101928)Ottawa Hospital Research Institute2021-11-30
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert (NCT05070728)EyePoint Pharmaceuticals, Inc.2021-10-13
Safety &Efficacy of CF101 to Subjects With Uveitis (NCT01905124)Can-Fite BioPharma2019-01-01
Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) (NCT03656692)Mallinckrodt2018-10-05
MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 (NCT02952001)Clearside Biomedical, Inc.2017-12-13
Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis (NCT03097315)Clearside Biomedical, Inc.2017-04-04
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis (NCT02595398)Clearside Biomedical, Inc.2015-11-17
Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis (NCT02255032)Clearside Biomedical, Inc.2014-10-01
Safety and Preliminary Efficacy Study of V404 PDS in Uveitis (NCT02125266)Forsight Vision42014-04-01
Study of the Effectiveness of Ozurdex for the Control of Uveitis (NCT02049476)Johns Hopkins University2014-01-01
Myfortic for the Treatment of Non-infectious Intermediate Uveitis (NCT01092533)STZ eyetrial2010-03-01
A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis (NCT00404612)Lux Biosciences, Inc.2007-01-01
A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis (NCT00404742)Lux Biosciences, Inc.2007-01-01
Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis (NCT00344253)Heidelberg University2006-03-01

Track Uveitis, Intermediate automatically

Every clearance here is in the API, with alerts when new ones post.